A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
News
Archived
•
October 22, 2026
•
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
Source: Washington Times | https://www.washingtontimes.com/rss/headlines/news/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


